In view of the profound functional and structural abnormalities shown in our previous studies in cultured, iron-loaded rat heart cells, we have examined the ability of the orally effective iron chelators dimethyl-3-hydroxypyrid-4-one (DMHP or L11 and diethyl-3-hydroxy-pyrid-4-one (DEHP or 0 4 ) and of deferoxamine (DF) t o reverse the damage caused by iron loading t o heart cell organelles. At a concentration of 1.0 mmol/L, all three iron chelators were equally efficient in removing iron and restoring the activity of the thiolic sarcolemmal enzymes 5'-nucleotidase and Na,K,ATPase. However, at 0.1 mmol/L DMHP and DEHP were less effective than DF both in their iron-mobilizing effect and in promoting thiolic enzyme recovery. The superior efficiency of DF at low concentrations illustrates the advantage of the hexadentate chelating action of DF as compared with bidentate chelators such as DMHP and DEHP requiring a 3 t o 1 AMAGE TO THE heart is one of the most critical manifestations of transfusional iron overload. Because no experimental model is presently available to simulate iron-induced heart disease in the intact animal, we have used rat myocardial cells in culture for studying the harmful effects of iron and the protective effects of iron ~helation."~ Our previous studies have shown that iron toxicity in heartcell cultures is associated with profound and reproducible changes in contractility and electrophysiologic behavio?,6; that these abnormalities are associated with evidence of increased lipid per~xidation~.~; and that these alterations may be prevented or reversed by deferoxamine (DF).
In view of the profound functional and structural abnormalities shown in our previous studies in cultured, iron-loaded rat heart cells, we have examined the ability of the orally effective iron chelators dimethyl-3-hydroxypyrid-4-one (DMHP or L11 and diethyl-3-hydroxy-pyrid-4-one (DEHP or 0 4 ) and of deferoxamine (DF) t o reverse the damage caused by iron loading t o heart cell organelles. At a concentration of 1.0 mmol/L, all three iron chelators were equally efficient in removing iron and restoring the activity of the thiolic sarcolemmal enzymes 5'-nucleotidase and Na,K,ATPase. However, at 0.1 mmol/L DMHP and DEHP were less effective than DF both in their iron-mobilizing effect and in promoting thiolic enzyme recovery. The superior efficiency of DF at low concentrations illustrates the advantage of the hexadentate chelating action of DF as compared with bidentate chelators such as DMHP and DEHP requiring a 3 t o 1 AMAGE TO THE heart is one of the most critical manifestations of transfusional iron overload. Because no experimental model is presently available to simulate iron-induced heart disease in the intact animal, we have used rat myocardial cells in culture for studying the harmful effects of iron and the protective effects of iron ~helation."~ Our previous studies have shown that iron toxicity in heartcell cultures is associated with profound and reproducible changes in contractility and electrophysiologic behavio?,6; that these abnormalities are associated with evidence of increased lipid per~xidation~.~; and that these alterations may be prevented or reversed by deferoxamine (DF).
In a recent study we have shown that thiolic sarcolemmal enzymes are a very sensitive target of iron toxicity and that increased lysosomal fragility, as evidenced by P-hexosaminidase activity, and peroxidative damage to thiolic sarcolemmal proteins may be important primary effects of iron toxicity.* The aim of the present studies was to examine the ability of the orally effective iron chelators dimethyl-3-hydroxypyrid-4-one (DMHP or Ll), diethyl-3-hydroxypyrid-4-one (DEHP or CP!94), and DF to reverse the sarcolemmal and molar ratio t o iron for optimal effect. In contrast to its beneficial effect on sarcolemmal enzyme activity, iron chelation was unable t o reverse the increase in B-hexosaminidase activity caused by abnormal lysosomal fragility. Our study demonstrates for the first time that iron-induced peroxidative damage to the myocardial cell is associated with a marked loss of Na,K,AlF+ase activity, an enzyme with a major role in the maintenance of cellular resting potential. The timing of this damage and the restoration of Na,K,ATPase function by iron-chelating treatment suggest a cause-andeffect relationship between the observed injury t o the sarcolemmal enzyme and the reversible electrophysiologic abnormalities observed in the same heart culture system in our previous studies. 0 1994 b y The American Society of Hematology.
lysosomal damage caused by iron loading in cultured heart cells.
MATERIALS AND METHODS
Ham F-l0 culture medium (GIBCO, Grand Island, NY) supplemented with 135 mg/L CaC12.Hz0, 200,000 U/L penicillin, 0.2 mgl L streptomycin, 10% horse serum, and 10% fetal bovine serum (Beth Ha'Emek, Israel) was used as growth medium. For iron-loading experiments, heterologous serum was replaced by serum-free medium. For mincing and washing the organs and for trypsinization, H solution (Ham F-l0 medium without calcium and magnesium) was used. Trypsin (type 111; Sigma Chemical CO, St Louis, MO) was dissolved in 0.1% wt/vol H solution.
Cell cultures. Cultures from l-day-old rats (Hebrew University strain) were obtained by methods described in detail in our previous s t~d i e s . ] .~.~ Briefly, the ventricles were minced and trypsinized and the combined fractions were resuspended in growth medium into a sterile 250-mL flask (Nunc; Nunclon Delta, Herlev, Denmark) through a sterile mesh to exclude explants. The pooled cells were diluted in growth medium to a density of 9 X lo5 to 1 X lo6 cells/ mL and seeded into a 35-mm diameter Petri dish (Falcon 3001; Falcon Labware, Oxnard, CA). This concentration yielded after 24 to 36 hours an almost confluent layer of beating heart cells at a final density of about 2 X lo6 cells. Cultures were kept at 37°C in an atmosphere of 5% COz and 95% air. Experiments were performed at 5 days of culture when more than 80% of the cells were beating myocardial cells. Continued viability of cultured iron-loaded cells was documented by supravital dye exclusion and by the absence of enzyme (lactate dehydrogenase) leakage into the culture medium after 24-hour iron loading.
Radioactive iron labeling. Radioactive iron labeling of heart cell cultures was performed by adding "Fe-citrate (specific activity, 3 to 20 pCi/pg; Amersham Radiochemical Centre, Amersham, UK) to the working iron-loading solution. Iron loading was achieved by using a stock solution of ferric ammonium citrate (BDH Fine Chemicals Ltd, Poole, UK) at a final concentration of 20 pg/mL elemental iron (0.36 mmoVL). The cellular concentration of iron after 24 hours of iron loading was 5.7 to 7.4 pglmg protein. To terminate incubations, the culture plates were washed twice with 1 mL cold saline. The cells were scraped by means of a rubber policeman, transferred into counting tubes, and resuspended in 0.5 mL culture medium. 59Fe activity was determined in an automatic well scintillation at 2,000 rpm for 10 minutes, was tested for protein content, and 0.7 mL was layered over 4 mL of 6.7% Percoll in sucrose-EDTA on a 0.3 mL cushion of 2.5 moVL sucrose in a quick-seal centrifuge tube (Beckman Instruments, Palo Alto, CA). The gradient was obtained by spinning in a Kontron I centrifuge (Centrikon T-2080; Kontron Instruments, Berne, Switzerland) using a VTI-65 vertical rotor at 20,000 rpm for 30 minutes with slow acceleration. The 250-pL fractions obtained were collected and assayed for protein by fluorescamine" and for enzyme activity as follows.
5'-Nucleozidase. 5'-Nucleotidase was assayed by the method of Aronson and Touster13 and the release of Pi was determined by the method of Ames.I4 P-Hexosaminidase. ,&Hexosaminidase was assayed by means of 4-methyl umbelliferyl-2-acetamido-2-deoxy-~-D-glycopyranoside (Sigma)." Lysosomal fragility was determined by calculating the percentage of free and latent P-hexosaminidase activity from the ratio of lysosomal enzyme activity in 0.25 moVL sucrose to enzyme activity in 0.1% Triton-100, as described by Mak and Weglicki.I6 Na,K,ATPase. Na,K,ATPase was measured as described by Lichstein et al." The cell homogenates were preincubated at 37°C for 10 minutes in 500 pL of medium containing a final concentration of 50 mmol/L Tris-HC1, pH 7.4, 100 mmol/L NaC1, 10 mmoVL KCl, and 4 mmoK MgClz. The reaction was started by the addition of 2 mmoVL vanadium-free ATP and stopped after 10 minutes by the addition of ice-cold 5% 12-0-tetradecanoylphorbol-13-acetate (TCA). The precipitate was removed by centrifugation and the enzyme activity measured in the supernatant by colorimetric determination of inorganic ph0~phate.l~ Basal Mg-ATPase activity was determined in the same samples in the presence of l mmoVL ouabain. Na,K,ATPase activity was calculated by subtracting Mg-ATPase from total ATPase activity. Enzyme activity was expressed as nanomoles of Pi per milligram of protein per minute.
Analysis of lipids. The pooled sarcolemmal fractions and the pooled lysosomal fractions derived from 25 culture plates were both extracted for analysis of lipid composition." The lipid extract was dried under nitrogen, redissolved in chloroform, and prepared for gas chromatography by transmethylation with methanolic trimethyl ammonium hydroxide (Met Prep 11; Applied Science, Deerfield,
LL).I9
Fatty acid analysis of the methyl esters was performed on a Hewlett Packard (Rockville, MD) 7620A GLC column (1.85 m X 4 mm id, 10% SP-2330 on 100/120 chromosorb in WAW 1-1851) with an injector temperature of 250°C and detector flame ionization at 250°C. Temperature programming was 5"C/min, starting at 150°C at 2 minutes postinjection, to a final temperature of 250°C. The flow rate of carrier nitrogen was 1.5 mL/min, of hydrogen was 16 mL/ min, and of air was 34 mL/min. The sample volumes were 5 pL. Fatty acid peaks were identified by comparing their retention times with known standards (Supelco, Bellefonte, PA). The internal standard for quantitative evaluation was heptadecanoic acid. Percentage composition of the samples was calculated using a Hewlett Packard 3380-S integrator. The integrated areas of the major fatty acid methyl esters were expressed as molar percentages.
Iron-chelating drugs. DMHP and DEHP were kindly supplied by Prof R.C. Hider (King's College, London, UK). They were syn- thesized and purified as previously described" and their purity was confirmed by 'H nuclear magnetic resonance, reverse-phase highperformance liquid chromatography, and elemental analysis. DF was supplied as the methane-sulphonate salt (Desferal) by Ciba-Geigy Ltd (Basel, Switzerland).
Design of experiments. All studies were performed on 5-dayold cultures. After iron loading for 24 hours with femc ammonium citrate, the cultures were washed with fresh medium and treated with the iron-chelating compounds at final concentrations of 0.1, 0.3, or 1.0 mmoVL for an additional 24 hours. All experiments were performed in quadruplicate sets of 5 culture plates for each experimental point. Negative (untreated control) and positive (iron-loaded nonchelated) control cultures were included in all studies. After iron chelation, cultures were maintained for an additional 24 hours to test for time-related spontaneous changes after iron-chelating treatment. Fisher's I-test was used for the statistical evaluation of differences in measurements obtained in experimental groups.
RESULTS
The effect of 2 4 hours of iron loading (20 pg irodml) of cultured heart cells on enzyme activity and membrane polyunsaturated fatty acid (PUFA) composition is described in Fig 1. The activity of the lysosomal enzyme P-hexosaminidase in whole-cell homogenates increased from 47. and iron-loaded whole-cell homogenates was 2.27% f 0.32% versus 2.01% 2 0.34% (NS) and of docosahexaenoic acid (22:6) was 3.55% 2 0.32% versus 3.15% 2 0.25% (P = .05), respectively.
In subsequent experiments, we have studied the ability of in vitro iron-chelating treatment to reverse the abnormalities induced by iron loading. Iron-loaded heart cells were subjected to 24 hours of incubation with DF, DMHP (CP20 or Ll), and D E W (Cp94) at concentrations of 0.1,0.3, and 1.0 mmoyL. In unchelated control cultures, cellular radioactivity after 24 hours of iron loading and an additional 24 hours of incubation in cold culture medium was 31.7% f 2.9% of the total "Fe added initially to the incubation mixture. This value was used to represent 100% radioiron in untreated control cells (Fig 2) . In vitro iron chelation resulted in a significant ( P < .001) decrease in cellular radioactivity at all drug concentrations tested. However, there was a major difference in the relative efficiency of the three chelators at low and high concentrations. At 0.1 mmol/L, residual radioiron concentration after DF treatment was 19.9% 2 1.3%, much less ( P < .001) than the 60.2% 2 6.0% after DMHP and 69.5% 2 8.5% after DEHP. Conversely, at 1.0 m o l / L residual cellular radioiron with DMHP (7.8% f 0.9%) and with DEHP (5.3% f 0.3%) was lower (P < .005) than with DF (11.3% 2 1.6%). At the intermediate concentration of 0.3 mmol/L, the chelating efficiency of all three drugs was similar.
In vitro iron-chelating therapy for 24 hours had a marked effect on both 5'-nucleotidase and Na,K,ATPase activity. There was a complete restoration to normal of both enzyme activities after 24 hours of incubation with all three iron chelators at a concentration of 1.0 mmol/L. However, at lower concentrations, the effects of these chelators on enzyme activity were dissimilar. At 0.1 mmol/L, DF treatment increased 5'-nucleotidase activity from 39% % 11% to 62% 2 2% of normal controls, whereas, in DMHP-and DEHPtreated cultures, enzyme activity was still 34% t-2% and 30% t-3%, respectively, of normal controls ( P < ,001; Fig   3) . This relative inefficiency of the 3-hydroxypyrid-4-one compounds was still maintained at a concentration of 0.3 mmol/L, with 95% t-S%, 47% ? 11%. and 43% t-9% activity for DF, DMHP, and DEHP, respectively ( P < .001).
With Na,K,ATPase, no such differences have been observed, and enzyme activity was restored to within the normal range (P > .05) at the lowest concentration of 0.1 mmol/L used with all three drugs (Fig 4; P < .001).
As mentioned earlier, @-hexosaminidase activity increased by iron loading to 169% t-32% of normal controls as a result of increased lysosomal fragility. In vitro iron chelation was unable to decrease hexosaminidase levels to pretreatment values (Fig 5) . This inability was not doserelated, and even at the highest chelator concentration of 1 .O mmoVL, hexosaminidase activities at 24 hours were still increased at 140% 2 2%, 149% 2 29%, and 162% 2 24% of normal controls for DF, DMHP, and DEHP, respectively Finally, we have examined the relationship between the duration of iron chelation in vitro and the rate of iron mobilization and restoration of enzyme activity (Table 1) . At a concentration of 1.0 mmol/L, all three drugs were very efficient in removing iron from heart cells, and total cellular radioactivity at 3 hours of chelation was already 23% or less than in untreated iron-loaded controls ( P < ,001). Neverthe-( P < .005). For personal use only. on October 30, 2017. by guest www.bloodjournal.org From DMHP, DEHP, AND DF less, at this time, 5'-nucleotidase activity still showed no improvement as compared with iron-loaded cells. In contrast, after 24 hours of iron chelation and a further decrease in cellular radioactivity to a range of 5% to 1 1 %, enzyme activity was restored to normal. There was no spontaneous release of radioiron and 40 alteration in 5'-nucleotidase activity when the cultures were maintained for an additional 24 hours in the absence of iron-chelating drugs. Similarly, the increased hexosaminidase levels of iron-loaded cells did not revert to normal when these cells were maintained in culture for an additional 24 hours after completion of in vitro ironchelating treatment.
DISCUSSION
The role of iron in promoting the conversion of superoxide and hydrogen peroxide into highly toxic free hydroxyl radicals through the Haber-Weiss reaction has been extensively documented." Damage associated with the generation of harmful oxygen-derived species may be manifested in increased membrane lipid peroxidation, degradation of DNA," proteins, or hyaluronic Previous studies of iron toxicity have suggested that m i t o c h~n d r i a ,~~*~ lysosomes,'6.26 and the sarcolemmal membrane6.*' may be particularly sensitive to iron-induced damage.
Although our previous studies in iron-loaded heart cells indicated increased lipid peroxidation as evidenced by increased cellular malondialdehyde and a slight depletion of PUFA, these changes were modest and could hardly be held responsible for the severe functional consequences of iron toxi~ity.4.~ Consequently, more subtle and sensitive indicators of lysosomal and sarcolemmal membrane damage were sought.
We have used the lysosomal enzyme 0-hexosaminidase as an indicator of iron-induced lysosomal damage. In a recent study,' we have found that in vitro iron loading of cultured heart cells is associated with a marked increase in total 0- hexosaminidase activity, and that this may be attributed to increased lysosomal fragility as evidenced by the loss of lysosomal latency and increased free enzyme activity. Increased lysosomal fragility associated with iron-mediated peroxidative injury has been found previously in hepatic lysosomes in animal models and in iron-loaded human tissues.16. 26 In contrast to lysosomal &hexosaminidase, the thiolic enzymes 5'-nucleotidase and Na,K,ATPase are located in the sarcolemma as well as in the plasma membrane of many other mammalian cells.28 The main function of 5"nucleotidase is the conversion of extracellular nucleotides into the corresponding nucleosides allowing their entry into cells. The SH group of 5'-nucleotidase is essential for its activity. Studies in thalassemic erythrocytes have shown an acquired inactivation of membrane 5'-nucleotidase, which is attributed to increased oxidative stress and inactivation of the enzyme SH-group by membrane lipid peroxidation products such as malondialdehyde (MDA).29,30 Na,K,ATPase is involved in the active transport and maintenance of intracellular Na' and K+ concentrations in the ATP.33 Modulation of intracellular Na' and K+ concentrations by altered Na,K,ATPase activity also results in an altered Na+/Ca+ exchange.34 Earlier studies have implied that a decline in Na,K,ATPase activity may be indirectly responsible for membrane depolarization by increasing cellular Na+ concentration and impairing electrical activity in the failing myocardium35 and in ischemia-reperfusion inj~ry.'~-~' Sulfhydryl groups reside in the active center of Na,K,ATPase and their alkylation results in the loss of enzyme a~tivity.~' As shown in the present studies, in vitro iron loading of cultured heart cells resulted in a marked decrease in the enzymatic activity of both 5'-nucleotidase and Na,K,ATPase. A similar inactivation of 5'-nucleotidase and Na,K,ATPase associated with iron-induced lipid peroxidation has been reported in mouse brain homogenates.w
In iron-overloaded rats, peroxidation of polyunsaturated fatty acids and the subsequent formation of highly reactive aldehydes such as MDA and 4-hydroxynonenal has been shown to result in the formation of covalent links to proteins, heaTt31.32 using the energy liberated by the hydrolysis of These links involve mainly the amino group of lysine residues and sulfhydryl groups!'
The reduction in the PUFA content of total cellular lipids and in various cellular fractions of iron-loaded heart cells and the increased MDA content of such cells documented in our previous studies13437 lend strong support to the contention that the observed loss of 5"nucleotidase and Na,K,ATPase activity may be attributed to the direct or indirect (via lipid peroxidation products) effects of increased oxidative stress on Sarcolemmal thiolic enzymes. Thus, the absence of major alterations in the composition of Sarcolemmal lipids, in conjunction with a marked decrease in Sarcolemmal 5'-nucleotidase and ATPase activity, imply that iron-induced peroxidative damage to membrane proteins may be a more important mechanism in the pathogenesis of altered myocardial function in the iron-loaded heart than formerly recognized. Because Na,K,ATPase plays a significant, although indirect role in cellular calcium homeostasis through the NdCa exchange mechanism, the observed inactivation of Na,K,ATPase by iron toxicity may provide a link between the structural and functional abnormalities observed in iron-loaded heart cells.
A particularly important aspect of the present studies was the reversibility of iron-induced abnormalities by in vitro chelating treatment. The reversibility of both 5'-nucleotidase and Na,K,ATPase inactivation by 24 hours of iron chelation confirms the specificity of the observed loss of activity by iron loading. Oxidative modification of proteins alters the overall charge, folding, and hydrophobicity of the protein and leads to enhanced proteolytic degradati~n.~, Although the design of our studies does not allow any conclusion regarding the mechanism of enzyme restoration, it is reasonable to assume that the observed improvement in enzyme activity is caused by a gradual replenishment of sarcolemmal enzymes by newly synthesized proteins in the absence of further iron toxicity. The inability of the same treatment to decrease lysosomal enzyme activity may indicate that it is easier to disrupt lysosomes than subsequently to restore organelle integrity.
The superior efficiency of DF at low concentrations is explained by the hexadentate chelating action of DF against the bidentate effect of the CP compounds requiring a 3 to 1 proportion of each molecule for one atom of As shown in our previous study," this does not necessarily mean that the effective molar concentrations of the CP compounds should always be 3 times those of DF. The problem only exists when the concentration of the CP compounds is too low, or if that of the chelatable iron pool too high to allow the formation of the inert [Fe-L,] complex.45 The practical implication of this limitation is that the risk of forming the potentially harmful polar intermediate complexes [Fe-L]*+ and [Fe-L,]+ is highest in patients with the most severe degrees of iron overload. This inherent limitation of the bidentate CP chelators is somewhat offset by their higher affinity to iron and their higher lipid solubility, facilitating their entry into cells and explaining their superior chelating efficiency when compared with DF at higher concentrations.
Our study shows for the first time that iron-induced peroxidative damage to the myocardial cell is associated with a marked loss of Na,K,ATPase activity, an enzyme that is directly responsible for the maintenance of cellular resting potential. The timing of this damage and the restoration of Na,K,ATPase function by iron-chelating treatment suggest a cause-and-effect relationship between the observed injury to the Sarcolemmal enzyme and the iron-induced impairment in contractility, the decrease in membrane potential, the loss of @adrenergic responsiveness, and the gross arrhythmias observed in the same heart culture system in our previous
The possibility of peroxidative damage to other proteins such as the SH groups of actin has not been addressed in the present studies.
It should also be emphasized that the present experimental model simulates acute iron toxicity, such as that observed after the ingestion of large amounts of iron, and not the chronic toxicity encountered after many years of slow iron accumulation. The concentrations of non-transferrin-bound iron used in our in vitro studies are 20 to 40 times higher than the nontransferrin plasma iron described by us and others in transfusional iron but are similar to those measured in acute iron poisoning. Nevertheless, iron concentrations in the heart in our in vitro model (5.7 to 7.4 pg iron/ mg protein) are very similar to those found by Fitchett et a147 in endocardial biopsies from hemochromatotic patients, and the concentrations of chelators used in our studies are within the range of serum chelator concentrations encountered in clinical studies!'
Although thiolic sarcolemmal membrane proteins appear to be an important target of acute iron toxicity, other organelles, such as the lysosomes, which are known to accumulate huge amounts of iron in chronic iron overload, may be the dominant site of iron toxicity in other circumstances. For personal use only. on October 30, 2017. by guest www.bloodjournal.org From
